Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Feb;34(2):355–357. doi: 10.1128/jcm.34.2.355-357.1996

Cost and time savings following introduction of rejection criteria for clinical specimens.

A J Morris 1, L K Smith 1, S Mirrett 1, L B Reller 1
PMCID: PMC228797  PMID: 8789015

Abstract

We have evaluated the yield of several tests and have instituted specimen rejection criteria to reduce costs and save time. For a 12-month period, we recorded the reduction of these tests and calculated the resultant cost and time savings. Seven changes were analyzed: not performing fungal or mycobacterial (acid-fast bacillus) cultures on cerebrospinal fluid (CSF) specimens from patients without known immunosuppression when chemistry and cell count are normal; not performing routine stool culture or ovum and parasite examination on specimens from patients in the hospital for > 3 days; not culturing endotracheal suction aspirates when no organisms or > 10 squamous epithelial cells are present; discontinuing broth cultures on all specimens except for tissue, continuous ambulatory peritoneal dialysis fluid, and CSF from patients with shunts; and eliminating bacterial antigen tests. For each test, the number not performed (n), reagent savings, and technologist time saved, respectively, were as follows: CSF fungal culture, 267, $999, and 67 h; CSF acid-fast bacillus culture, 275, $1,662, and 124 h; stool cultures, 320, $2,991, and 98 h; ovum and parasite examinations, 216, $525, and 108 h; endotracheal suction aspirate cultures, 1,505, $4,447, and 306 h; broth cultures, 5,218, $4,931, and 80 h; and bacterial antigen tests, 2,598, $2,293, and 299 h. Overall, 5,181 tests were rejected and 5,218 broth cultures were omitted. Achievable savings were $28,000 in reagent costs and 1,082 h of technologist time. In conclusion, rejecting specimens of proven low yield saves reagent costs and, more importantly, saves technologist time. This time can be spent on specimens having greater diagnostic utility.

Full Text

The Full Text of this article is available as a PDF (151.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albright R. E., Jr, Graham C. B., 3rd, Christenson R. H., Schell W. A., Bledsoe M. C., Emlet J. L., Mears T. P., Reller L. B., Schneider K. A. Issues in cerebrospinal fluid management. Acid-fast bacillus smear and culture. Am J Clin Pathol. 1991 Mar;95(3):418–423. doi: 10.1093/ajcp/95.3.418. [DOI] [PubMed] [Google Scholar]
  2. Asch D. A., Hershey J. C. Why some health policies don't make sense at the bedside. Ann Intern Med. 1995 Jun 1;122(11):846–850. doi: 10.7326/0003-4819-122-11-199506010-00007. [DOI] [PubMed] [Google Scholar]
  3. Bishburg E., Sunderam G., Reichman L. B., Kapila R. Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann Intern Med. 1986 Aug;105(2):210–213. doi: 10.7326/0003-4819-105-2-210. [DOI] [PubMed] [Google Scholar]
  4. Bowman R. A., Bowman J. M., Arrow S. A., Riley T. V. Selective criteria for the microbiological examination of faecal specimens. J Clin Pathol. 1992 Sep;45(9):838–839. doi: 10.1136/jcp.45.9.838. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brady M. T., Pacini D. L., Budde C. T., Connell M. J. Diagnostic studies of nosocomial diarrhea in children: assessing their use and value. Am J Infect Control. 1989 Apr;17(2):77–82. doi: 10.1016/0196-6553(89)90021-7. [DOI] [PubMed] [Google Scholar]
  6. Fan K., Morris A. J., Reller L. B. Application of rejection criteria for stool cultures for bacterial enteric pathogens. J Clin Microbiol. 1993 Aug;31(8):2233–2235. doi: 10.1128/jcm.31.8.2233-2235.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gyorkos T. W., MacLean J. D., Law C. G. Absence of significant differences in intestinal parasite prevalence estimates after examination of either one or two stool specimens. Am J Epidemiol. 1989 Nov;130(5):976–980. doi: 10.1093/oxfordjournals.aje.a115430. [DOI] [PubMed] [Google Scholar]
  8. Ilstrup D. M. Randomized clinical trails: potential cost savings due to the identification of ineffective medical therapies. Mayo Clin Proc. 1995 Jul;70(7):707–710. doi: 10.4065/70.7.707. [DOI] [PubMed] [Google Scholar]
  9. Kaplan M. H., Rosen P. P., Armstrong D. Cryptococcosis in a cancer hospital: clinical and pathological correlates in forty-six patients. Cancer. 1977 May;39(5):2265–2274. doi: 10.1002/1097-0142(197705)39:5<2265::aid-cncr2820390546>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  10. Karandanis D., Shulman J. A. Recent survey of infectious meningitis in adults: review of laboratory findings in bacterial, tuberculous, and aseptic meningitis. South Med J. 1976 Apr;69(4):449–457. doi: 10.1097/00007611-197604000-00021. [DOI] [PubMed] [Google Scholar]
  11. Kassirer J. P. Managed care and the morality of the marketplace. N Engl J Med. 1995 Jul 6;333(1):50–52. doi: 10.1056/NEJM199507063330110. [DOI] [PubMed] [Google Scholar]
  12. Kent S. J., Crowe S. M., Yung A., Lucas C. R., Mijch A. M. Tuberculous meningitis: a 30-year review. Clin Infect Dis. 1993 Dec;17(6):987–994. doi: 10.1093/clinids/17.6.987. [DOI] [PubMed] [Google Scholar]
  13. Kiska D. L., Jones M. C., Mangum M. E., Orkiszewski D., Gilligan P. H. Quality assurance study of bacterial antigen testing of cerebrospinal fluid. J Clin Microbiol. 1995 May;33(5):1141–1144. doi: 10.1128/jcm.33.5.1141-1144.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Klein N. C., Damsker B., Hirschman S. Z. Mycobacterial meningitis. Retrospective analysis from 1970 to 1983. Am J Med. 1985 Jul;79(1):29–34. doi: 10.1016/0002-9343(85)90542-x. [DOI] [PubMed] [Google Scholar]
  15. Koplan J. P., Fineberg H. V., Ferraro M. J., Rosenberg M. L. Value of stool cultures. Lancet. 1980 Aug 23;2(8191):413–416. doi: 10.1016/s0140-6736(80)90453-5. [DOI] [PubMed] [Google Scholar]
  16. Kovacs J. A., Kovacs A. A., Polis M., Wright W. C., Gill V. J., Tuazon C. U., Gelmann E. P., Lane H. C., Longfield R., Overturf G. Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med. 1985 Oct;103(4):533–538. doi: 10.7326/0003-4819-103-4-533. [DOI] [PubMed] [Google Scholar]
  17. Morris A. J., Tanner D. C., Reller L. B. Rejection criteria for endotracheal aspirates from adults. J Clin Microbiol. 1993 May;31(5):1027–1029. doi: 10.1128/jcm.31.5.1027-1029.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Morris A. J., Wilson M. L., Reller L. B. Application of rejection criteria for stool ovum and parasite examinations. J Clin Microbiol. 1992 Dec;30(12):3213–3216. doi: 10.1128/jcm.30.12.3213-3216.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Morris A. J., Wilson S. J., Marx C. E., Wilson M. L., Mirrett S., Reller L. B. Clinical impact of bacteria and fungi recovered only from broth cultures. J Clin Microbiol. 1995 Jan;33(1):161–165. doi: 10.1128/jcm.33.1.161-165.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Perkins M. D., Mirrett S., Reller L. B. Rapid bacterial antigen detection is not clinically useful. J Clin Microbiol. 1995 Jun;33(6):1486–1491. doi: 10.1128/jcm.33.6.1486-1491.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Reller L. B., Mirrett S. Motility-indole-lysine medium for presumptive identification of enteric pathogens of Enterobacteriaceae. J Clin Microbiol. 1975 Sep;2(3):247–252. doi: 10.1128/jcm.2.3.247-252.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schröter G. P., Temple D. R., Husberg B. S., Weil R., 3rd, Starzl T. E. Cryptococcosis after renal transplantation: report of ten cases. Surgery. 1976 Mar;79(3):268–277. [PMC free article] [PubMed] [Google Scholar]
  23. Siegel D. L., Edelstein P. H., Nachamkin I. Inappropriate testing for diarrheal diseases in the hospital. JAMA. 1990 Feb 16;263(7):979–982. [PubMed] [Google Scholar]
  24. Yannelli B., Gurevich I., Schoch P. E., Cunha B. A. Yield of stool cultures, ova and parasite tests, and Clostridium difficile determinations in nosocomial diarrheas. Am J Infect Control. 1988 Dec;16(6):246–249. doi: 10.1016/s0196-6553(88)80003-8. [DOI] [PubMed] [Google Scholar]
  25. Zuger A., Louie E., Holzman R. S., Simberkoff M. S., Rahal J. J. Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med. 1986 Feb;104(2):234–240. doi: 10.7326/0003-4819-104-2-234. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES